STOCK TITAN

Travelers Compan Form 4 Filings

TRV NYSE

Every Form 4 that Travelers Compan (TRV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow TRV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TRV filings page.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. (TRV) executive Maria Olivo, EVP, ERM & Chief Risk Officer, reported selling 6,000 shares of common stock on 2026-08-28 in an open-market or private transaction at a weighted average price of $369.8575 per share, with individual trade prices ranging from $369.81 to $369.962. Following this sale, she directly held 118,742.457 common shares and indirectly held 343.956 shares through a 401(k) Plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. (TRV) reported that director Anthony M. Jabbour received an award of 446 deferred stock units of common stock on August 14, 2026. The units, valued at $370.36 per share, were granted under the company’s Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. These deferred stock units convert into an equal number of common shares upon distribution, which occurs in a lump sum or annual installments beginning at least six months after the end of his board service. Following this award, Jabbour directly holds 446 units and indirectly holds 114 shares in trust.

Rhea-AI Summary

Travelers Companies, Inc. executive Daniel Tei-Hwa Yin, EVP & Co-Chief Investment Officer, exercised stock options covering 7,153 shares of common stock at $140.85 per share on July 24, 2026, then sold 7,153 shares of common stock in a sale transaction at $387.00 per share the same day.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Diane Kurtzman reported a same‑day option exercise and share sale. On 2026‑07‑24 she exercised stock options for 4164 shares of Common Stock at $132.58 per share, then sold 4164 shares at $386.71 per share. The exercised option grant now shows no remaining derivative shares.

Rhea-AI Summary

Travelers Companies EVP & Co-Chief Investment Officer David Donnay exercised 5,000 stock options for common shares at $132.58 per share on July 22, 2026, then sold 5,000 common shares at $371.688 per share in an open-market or private transaction.

After the option exercise, he held 22,755 stock options and indirect holdings of 5,923.492 shares through a 401(k) plan and 22,083 shares in trust.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Paul E. Munson, SVP & Corp. Controller, reported an options exercise and same-day sale on July 22, 2026. He exercised stock options for 1,525 shares of common stock at $126.18 per share and sold 1,525 common shares at $369.905 per share. The reported stock option position from this grant now shows 0 shares remaining.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive BESSETTE ANDY F, EVP and Chief Admin Officer, reported selling 3,000 shares of common stock on July 22, 2026 in transactions coded as sales in open market or private transactions. The sales included 2,900 shares at a weighted average price of $368.0865 (with individual prices ranging from $367.86 to $368.84) and 100 shares at $368.8650. He also reported 1,720.988 shares of common stock held indirectly through a 401(k) Plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. EVP Michael Frederick Klein exercised 6,000 stock options for Common Stock at an exercise price of $139.83 per share and on 2026-07-21 sold 6,000 shares in two open-market transactions at weighted average prices of $364.9033 and $366.1189 per share. After these transactions, he held 30,037 stock options directly and 1,895.088 shares of Common Stock indirectly through a 401(k) Plan.

Rhea-AI Summary

Travelers Companies, Inc. EVP & Chief Financial Officer Daniel S. Frey reported option-related trades on July 21, 2026. He exercised stock options for a total of 14,037 shares of common stock at strike prices of $139.83 and $172.50 per share, acquired the underlying shares, and sold 11,037 shares at a weighted-average price of $368.1641 (range $368.11–$368.45) and 3,000 shares at $368.5250 in open market or private transactions.

Rhea-AI Summary

Mojgan M Lefebvre, EVP & Chief Tech & Ops Officer of Travelers Companies, Inc., exercised stock options for 9,213 shares at $132.5800 and 7,100 shares at $139.8300 on July 21, 2026, receiving common stock and selling 9,213 shares at a weighted-average $368.3547 (for prices from $368.16 to $368.57) and 7,100 shares at $368.4050, for total sales of 16,313 shares.

Rhea-AI Summary

Travelers Companies director Elizabeth Robinson received a grant of 132.53 deferred common stock units on June 30, 2026, in lieu of cash fees under the company’s Deferred Compensation Plan for Non-Employee Directors. Each unit will convert into one share of common stock upon distribution. After this award and additional units credited through dividend reinvestment, she holds a total of 12,561.986 deferred common stock units.

Rhea-AI Summary

Travelers Companies director Russell G. Golden reported an award of 140.1 deferred common stock units on Company stock. These units were granted in lieu of cash compensation under the Deferred Compensation Plan for Non-Employee Directors at a reference value of $330.12 per share. The award increases his direct deferred unit holdings to 5,599.757, which also include 20.595 units acquired on June 30, 2026 through the plans’ dividend reinvestment features. The deferred units will convert into the same number of Travelers common shares upon distribution, which can occur in a lump sum or annual installments at the director’s election.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported a mix of option exercise and share sales in Common Stock. He exercised 10,000 stock options at a price of $132.58 per share, converting them into an equal number of common shares.

On the same date, he completed open-market sales totaling 10,000 shares of Common Stock across three transactions: 1,519 shares at a weighted average of $308.792, 2,412 shares at $308.333, and 6,069 shares at $307.1003. After these transactions, he directly holds 49,055.787 shares of Common Stock and indirectly holds 1,888.345 shares through a 401(k) Plan.

Footnotes state that the sale prices are weighted averages over stated price ranges, and full price breakdowns are available upon request to the company or regulators.

Rhea-AI Summary

Travelers Companies EVP and Chief Admin Officer Andy F. Bessette reported an option exercise and related share sale. On May 22, 2026, he exercised stock options to acquire 4,255 shares of common stock at $189.01 per share, then sold 4,255 shares in an open-market transaction at $308.11 per share.

After these transactions, Bessette directly held 24,284.397 shares of Travelers common stock and indirectly held 1,714.863 shares through a 401(k) Plan. No remaining derivative position is shown for the exercised options.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, reported a bona fide gift of 1,000 shares of Common Stock. This transfer is not an open-market sale. After the gift, he directly holds 47,737.422 shares.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. Vice Chairman and Chief Legal Officer Avrohom J. Kess exercised stock options and disposed of some resulting shares. He exercised 27,686 stock options at an exercise price of $140.85 per share, receiving the same number of common shares.

Of these, 20,951 shares were used to satisfy tax obligations at an effective value of $309.03 per share, and 6,735 shares were sold in an open-market sale at $308.781 per share. After the transactions, he held 48,737.422 shares of Travelers common stock directly, indicating he retained a substantial equity position.

Rhea-AI Summary

Travelers Companies Vice Chairman William H. Heyman exercised stock options and sold shares of common stock. He exercised 1,557 shares from stock options at $189.01 per share, then sold 1,000 shares at $311.00 and 557 shares at $310.00 in open-market transactions on the same date. After these moves, he directly holds 259,590 shares of Travelers common stock. Additional indirect holdings include shares held in a trust for his stepson, by his spouse, and in a 401(k) plan, for which he disclaims beneficial ownership.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. director Laurie J. Thomsen reported a bona fide gift of 631 shares of Common Stock on April 23, 2026, transferred at a reported price of $0.0000 per share. After the gift, she directly holds 62,178.076 shares of Travelers common stock.

In addition, filings show 303 shares held indirectly through an IRA and 200 shares held indirectly by a spouse. A footnote states that her position includes 1,189.844 deferred stock units acquired since February 4, 2025 under the dividend reinvestment feature of the company’s Deferred Compensation Plan for Non-Employee Directors.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Diane Kurtzman reported an exercise-and-sell transaction in company stock. On April 20, 2026, she exercised stock options to acquire 1,387 shares of common stock at an exercise price of $132.58 per share.

On the same date, she sold a total of 2,867 shares of common stock in open‑market transactions at weighted average prices of approximately $303.42 and $303.47 per share. After these transactions, she directly owns 5,298.209 shares of common stock and holds 4,164 stock options that are exercisable for common stock and expire on February 4, 2030.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported option exercises and same-day share sales in common stock. He exercised stock options covering 10,000 shares at an exercise price of $132.58 per share, converting them into common stock.

On the same date, he sold 3,270 shares at an average price of $304.3846 and 6,730 shares at an average price of $303.47 in open-market transactions, totaling 10,000 shares sold. After these transactions, he directly owned 45,124.787 shares of common stock and indirectly held 1,888.708 shares through a 401(k) plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, reported a bona fide gift of 2,125 shares of common stock. This is a non-market transfer with no sale proceeds. After the gift, he directly holds 48,737.422 shares of Travelers common stock.

Rhea-AI Summary

Travelers Companies EVP Jeffrey P. Klenk, EVP & President, Bond & Specialty Insurance, reported an open-market sale of Common Stock. On April 20, 2026, he sold 6,413.654 shares of Travelers Companies at $305.06 per share. After the transaction, he directly held 6,075.303 shares of Common Stock.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. director Elizabeth Robinson received a grant of 149.99 deferred common stock units at $291.68 per unit under the company’s non-employee director compensation plans. These deferred units are issued in lieu of cash compensation and will convert into shares of common stock on a one-for-one basis when distributed.

After this grant, Robinson holds a total of 12,382.571 deferred common stock units, including 45.955 units acquired on March 31, 2026 through dividend reinvestment features. Distribution of the underlying shares will occur at her election, either in a lump sum or in annual installments.

Rhea-AI Summary

Travelers Companies director Russell G. Golden received 158.560 deferred common stock units as compensation. The units were valued at $291.68 per share equivalent and are part of the Company’s Deferred Compensation Plan for Non-Employee Directors.

After this grant and related dividend reinvestment, Golden holds a total of 5,439.062 deferred common stock units, including 19.839 units acquired through the plans’ dividend reinvestment features. These units will convert into an equal number of Travelers common shares upon distribution, which can occur in a lump sum or annual installments at the director’s election.

Rhea-AI Summary

Travelers Companies executive David Donnay exercised 4,731 stock options and sold the same number of shares. On the same day, he converted options into 4,731 common shares at an exercise price of $126.18 per share, then sold 4,731 shares in open-market transactions at a weighted average price of $308.5191 per share.

After these trades, Donnay directly owned 10,478.629 common shares. He also held additional indirect interests, including 5,881.556 shares through a 401(k) plan and 22,083 shares held in trust. The filing notes the sale price is a weighted average across individual trades between $308.18 and $308.62.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Maria Olivo exercised stock options for 10,400 shares and then sold 10,400 shares of common stock in an open-market transaction on 2026-02-26. The sale price reflected a weighted average of $306.595 per share across trades in a narrow price range.

Following these transactions, Olivo directly owned 124,742.457 shares of common stock and indirectly held 341.736 shares through a 401(k) plan. The option exercise was reported as a derivative conversion, with the subsequent sale classified as an open-market sale.

Rhea-AI Summary

Travelers Companies senior vice president Paul E. Munson reported mixed insider activity involving stock options and common shares. On 2026-02-25, he exercised stock options for 2,800 shares at $126.18 per share through a derivative exercise.

That exercise delivered 2,800 shares of common stock, and he then executed open-market sales totaling 3,727 common shares at $306.04 per share, leaving him with 735.338 shares of directly owned common stock after the transactions.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. vice chairman William H. Heyman reported option exercises and related stock sales in February 2026. He exercised stock options and acquired a total of 5,000 shares of common stock at exercise prices including $172.50 and $189.01 per share.

On the same dates, he executed open-market sales totaling 5,000 shares at prices including $304.00, $305.00, $307.8775 and $309.0001 per share, resulting in a net 5,000-share sale and leaving 259,590 shares held directly after the transactions. In addition, indirect accounts such as a 401(k) plan, spouse holdings and a trust hold 1,716.895, 2,256 and 250 shares respectively, and he disclaims beneficial ownership of these indirect shares.

Rhea-AI Summary

Travelers Companies executive Daniel Tei-Hwa Yin, EVP & Co-Chief Investment Officer, reported option-related transactions in company stock. He exercised 8,470 stock options, converting them into an equal number of common shares at an exercise price of $118.78 per share. To cover the exercise price or related tax obligations, 5,904 common shares were disposed of at $302.20 per share as a tax-withholding transaction, not an open-market sale. After these transactions, he directly owned 68,834.051 common shares of Travelers Companies.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Gregory C. Toczydlowski, EVP & President, Business Insurance, reported an open-market sale of 12,199.69 shares of common stock on February 20, 2026 at a weighted average price of $299.7604 per share, with trades executed between $299.71 and $300.17.

After this sale, he directly holds 18,416.187 shares of Travelers common stock and indirectly holds 285.651 shares through a 401(k) Plan.

Rhea-AI Summary

Travelers Companies, Inc. Executive Vice President and Chief Financial Officer Daniel S. Frey sold 8,000 shares of common stock in an open-market transaction on February 20, 2026 at an average price of $299.495 per share. After this sale, he directly owns 27,534.948 common shares.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Avrohom J. Kess, Vice Chairman and Chief Legal Officer, exercised stock options for 20,000 shares on 2026-02-20, acquiring 20,000 shares of common stock at $140.8500 per share. To cover related obligations, he disposed of 15,244 shares in a tax-withholding transaction at $300.9800 per share and sold 4,756 shares in open-market trades at a weighted average price of $300.4417 per share, with individual sale prices ranging from $300.38 to $300.60. After these transactions, he directly owned 50,862.4220 shares of Travelers common stock.

Rhea-AI Summary

Travelers Companies EVP & Chief Tech & Ops Officer Mojgan M. Lefebvre reported a mix of equity award, tax withholding, and stock sale transactions in company common stock. On February 18, 2026, she acquired 12,008.654 shares through a grant/award tied to performance share rights granted in 2023, and on the same date disposed of 6,182.000 shares to cover tax obligations at $298.4600 per share, leaving 5,826.654 shares directly owned.

On February 19, 2026, she completed an open‑market sale of 5,826.654 shares of common stock at a weighted average price of $298.2527 per share, with actual prices ranging from $298.25 to $298.32, resulting in 0 shares of common stock held directly after the sale.

Rhea-AI Summary

Travelers Companies executive Daniel Tei-Hwa Yin reported equity compensation activity involving company common stock. He acquired 9,238.244 shares through a grant or award tied to performance share rights granted in 2023, reflecting achievement of specified performance objectives. On the same date, 4,627 shares were disposed of to satisfy tax withholding obligations at a price of $298.46 per share. After these transactions, he directly held 66,268.051 shares of Travelers Companies common stock.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive David Donnay, EVP & Co-Chief Investment Officer, received 9,238.244 shares of common stock as a grant tied to performance share rights awarded in 2023. These shares were paid out after the company confirmed achievement of the relevant performance objectives.

On the same date, 4,225 shares were disposed of at $298.4600 per share to cover tax liabilities through share withholding rather than a market sale. Following these transactions, Donnay directly owns 10,478.629 shares, with additional indirect holdings in a 401(k) plan and in a trust.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Gregory C. Toczydlowski reported equity compensation activity in company common stock. He received a grant/award acquisition of 22,842.69 shares on February 18, 2026 at a stated price of $0.0000 per share, representing common stock paid out upon achievement of performance objectives from performance share rights granted in 2023. To cover tax obligations, 10,643 shares were disposed of through a tax-withholding transaction at $298.46 per share on the same date. Following these transactions, his directly owned common stock holdings were 30,615.877 shares, and he also had 285.651 shares held indirectly in a 401(k) plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Michael Frederick Klein reported mixed equity transactions in company common stock. He acquired 21,498.756 shares on a grant/award basis, representing common stock paid out upon achievement of performance objectives from performance share rights granted in 2023. On the same date, 10,012 shares were disposed of at 298.4600 per share to cover tax liabilities by delivering securities, a tax-withholding disposition rather than an open-market sale. After these transactions, he held 45,124.787 shares directly and 1,881.671 shares indirectly through a 401(k) plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. Chairman and CEO Alan D. Schnitzer reported equity compensation activity in company common stock. He acquired 95,739.098 shares as a payout upon achievement of performance objectives from performance share rights granted in 2023, at a stated price of $0.0000 per share.

On the same date, 52,944 shares were disposed of at $298.4600 per share in a tax-withholding disposition to satisfy exercise price or tax liability, leaving him with 303,124.499 shares held directly. An additional 11,091 shares are held indirectly by his spouse, and he disclaims beneficial ownership of those securities.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. Vice Chairman and Chief Legal Officer Avrohom J. Kess reported a mix of equity compensation activity in company common stock. He acquired 19,147.394 shares on February 18, 2026 as a grant or award at a stated price of $0.0000 per share, representing common stock paid out upon achievement of performance objectives from performance share rights granted in 2023. On the same date, 10,172 shares were disposed of at $298.4600 per share in a tax-withholding transaction to cover obligations by delivering shares rather than selling them in the open market. Following these transactions, he directly owns 50,862.422 shares of Travelers common stock.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Maria Olivo, EVP, ERM & Chief Risk Officer, reported a stock-based compensation event and related tax share withholding in company common stock.

Olivo acquired 13,856.308 shares of common stock at a stated price of $0.00 per share in a grant classified as a “grant, award, or other acquisition.” According to the disclosure, these shares represent common stock paid out upon achievement of performance objectives from performance share rights originally granted in 2023.

On the same date, 6,710 shares of common stock were disposed of at $298.46 per share in a tax-withholding disposition used to satisfy tax obligations by delivering shares rather than an open‑market sale. After these transactions, Olivo directly held 124,742.457 shares of common stock and indirectly held 341.736 shares through a 401(k) plan.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. Vice Chairman William H. Heyman reported several equity transactions in company stock. He received 10,078.466 shares of common stock on February 18, 2026 as a payout for performance share rights granted in 2023. To cover tax obligations, 5,574 shares were withheld at a price of $298.46 per share. On February 17, 2026, he exercised options for 1,000 shares at $172.50 per share and sold 1,000 shares in an open-market transaction at $300.00 per share. After these transactions, he directly held 259,590 shares of common stock, with additional indirect holdings through a 401(k) plan, his spouse, and a trust for his stepson, for some of which he disclaims beneficial ownership.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive vice president and chief financial officer Daniel S. Frey reported mixed equity transactions in company stock. On February 18, 2026, he acquired 16,125.128 shares of common stock at no cost, representing common stock paid out upon achievement of performance objectives from performance share rights granted in 2023. On the same date, 7,522 shares were disposed of at $298.46 per share to satisfy tax withholding obligations, rather than an open-market sale. Following these transactions, Frey directly holds 35,534.948 shares of Travelers common stock.

Rhea-AI Summary

Travelers Companies, Inc. senior vice president and corporate controller Paul E. Munson reported performance-based equity activity in company common stock. He acquired 1,341.824 shares at no cost through a grant tied to 2023 performance share rights, and 414 shares were disposed of to cover tax obligations at a price of $298.46 per share. After these Form 4 transactions, his directly held common stock position totaled 1,662.338 shares.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Diane Kurtzman, EVP & Chief HR Officer, reported two common stock transactions. She acquired 6,046.660 shares at a price of $0.0000, representing common stock paid out upon achievement of performance objectives from performance share rights granted in 2023.

On the same date, 3,087.000 shares were disposed of in a tax-withholding transaction at $298.4600 per share to cover tax obligations by delivering shares. After these transactions, her directly held common stock position was 6,778.209 shares.

Rhea-AI Summary

TRAVELERS COMPANIES, INC. executive Andy F. Bessette, EVP and Chief Admin Officer, reported a mix of equity awards, option exercises, sales, and other dispositions in company stock. On February 17, 2026, he exercised stock options covering 6,000 shares, which were converted into common stock, and then sold a total of 6,000 common shares in multiple open-market transactions at weighted average prices ranging from about $296.80 to $299.22, according to the footnotes. He also made a bona fide gift of 417 common shares and reported an indirect holding of 1,708.799 shares in a 401(k) plan. On February 18, 2026, he received a grant of 8,230.82 common shares upon achievement of performance objectives from 2023 performance share rights and used 3,821 shares to cover taxes, leaving 24,284.397 common shares held directly after these transactions.

Rhea-AI Summary

Travelers Companies executive Jeffrey P. Klenk reported equity compensation activity in company common stock. He acquired 12,008.654 shares on a grant or award basis at a stated price of $0.0000 per share, representing common stock paid out upon achievement of 2023 performance share objectives.

On the same date, 5,595 shares were disposed of in a tax-withholding transaction at $298.4600 per share to cover obligations tied to this award. After these transactions, his directly owned holdings stood at 12,488.957 shares of Travelers common stock.

Rhea-AI Summary

Travelers Companies executive Maria Olivo reported an option exercise and share sale. On February 6, 2026, she exercised 10,400 stock options at $118.78 per share, acquiring the same number of Travelers common shares.

The same day, she sold 10,400 common shares at a weighted average price of $300.7531, with actual prices ranging from $300.72 to $300.87. After these transactions, she directly held 117,596.149 common shares and indirectly held 341.736 shares through a 401(k) plan.

Rhea-AI Summary

The Travelers Companies, Inc. executive Michael Frederick Klein, EVP & President, Personal Insurance, reported option and stock transactions. On February 6, 2026, he exercised 10,000 stock options at $132.58 per share, acquiring 10,000 shares of common stock.

That same day, he sold 10,000 shares of Travelers common stock at a weighted average price of $301.1783 per share. After these transactions, Klein directly held 33,638.031 shares of common stock and indirectly held 1,881.671 shares through a 401(k) plan. He continued to hold 20,000 stock options following the reported activity.

Rhea-AI Summary

The Travelers Companies, Inc. vice chairman William H. Heyman reported exercising stock options and selling common shares of Travelers. On February 5 and 6, 2026, he exercised a total of 6,000 stock options at $172.5 per share and sold 6,000 common shares at prices of $302 and $303 per share. After these transactions, he directly held 255,085.534 shares of Travelers common stock and 3,000 stock options. Additional common shares are held indirectly in a 401(k) plan, by his spouse, and in a trust for his stepson, and he disclaims beneficial ownership of those indirect holdings.

Rhea-AI Summary

The Travelers Companies officer Paul E. Munson, SVP & Corporate Controller, reported a new grant of stock options in the company. On February 3, 2026, he was awarded 1,165 stock options with a $288.23 exercise price, expiring between February 3, 2029 and February 3, 2036. Following this grant, he directly holds 1,165 derivative securities linked to Travelers common stock.